Lee, Danner & Bass’s Sanofi SNY Stock Holding History

Lee, Danner & Bass’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-652	Closed	-$31.4K	–	638
2024 Q4	$31.4K	Buy	+652	New	+$33.2K	﹤0.01%	403

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lee, Danner & Bass's SNY Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Sanofi (SNY) in Q1 2025, closing a stake of 652 shares — an estimated $31.4K sold.

Lee, Danner & Bass first reported a position in SNY in Q4 2024 and held it in 1 quarter. The position peaked at $31.4K in Q4 2024. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

Lee, Danner & Bass reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 652 Sanofi shares in Q1 2025, an estimated $31.4K.
Lee, Danner & Bass first reported a position in Sanofi in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's Sanofi position peaked at $31.4K in Q4 2024.
771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.